lopez kind sir. Theres obviously a chance that stem cells will pass on cancerous cells. we know that , the whole stem cell community knows that? Thats why a single donor of healthy origin is so important, it reduces the the mathematical likelihood of cancerous cells being passed on from each new multi donor batch?? I bet SI is kicking himself for not buying it.. Think...IPSCs nobel prize, cynerus front page of Nature Magazine. I hope for the childrens sake the FDA approves msbs latest application, the children have very.littke hope otherwise. But for future applications multiple donor stem cells wont pass FDA critical quality assurance..exactly becoz of the increased chance of some variant being pass on.in the new donor cells!! Cymerus single donor IPSCs are the leader..what all shareholders need is Cymerus with an SI type CEO...imagine where we would all. be sitting now. instead of wondering how much lower these SPs will go and how much more B/S we have to put up with from highly paid non performing boards.
CYP Price at posting:
31.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)